Skip to main content
. 2017 Aug 15;117(8):1202–1210. doi: 10.1038/bjc.2017.266

Figure 3.

Figure 3

Preoperative plasma miR31 and 29a can discriminate patients developing recurrence. Analyses of receive operating characteristic (ROC) curve showed prognostic power of plasma miR31 (AUC: 0.717 (95% CI: 0.439, 0.995)) and miR29a (AUC: 0.703 (95% CI: 0.562, 0.845)), which could discriminate patients with recurrence from these without recurrence.